Drug XPro of INmune Bio has limitless potential in neurodegenerative diseases such as Alzheimers, ALS, MS, Huntington's, Parkinson's, ...

Introduction I believe INmune Bio, a company with a market cap of just 200 million dollars at the time of writing, will end up being...